BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32655007)

  • 1. Metabolomics Analysis of Aspirin's Effects in Human Colon Tissue and Associations with Adenoma Risk.
    Barry EL; Fedirko V; Uppal K; Ma C; Liu K; Mott LA; Peacock JL; Passarelli MN; Baron JA; Jones DP
    Cancer Prev Res (Phila); 2020 Oct; 13(10):863-876. PubMed ID: 32655007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Metabolomics Analysis of Aspirin Treatment and Risk of Colorectal Adenomas.
    Barry EL; Fedirko V; Jin Y; Liu K; Mott LA; Peacock JL; Passarelli MN; Baron JA; Jones DP
    Cancer Prev Res (Phila); 2022 Aug; 15(8):521-531. PubMed ID: 35653338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
    Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
    Trials; 2013 Jul; 14():237. PubMed ID: 23895505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS).
    Fedirko V; Bradshaw PT; Figueiredo JC; Sandler RS; Barry EL; Ahnen DJ; Milne GL; Bresalier RS; Baron JA
    Cancer Prev Res (Phila); 2015 Nov; 8(11):1061-8. PubMed ID: 26304466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Low-dose and Standard-dose Aspirin on PGE
    Drew DA; Schuck MM; Magicheva-Gupta MV; Stewart KO; Gilpin KK; Miller P; Parziale MP; Pond EN; Takacsi-Nagy O; Zerjav DC; Chin SM; Mackinnon Krems J; Meixell D; Joshi AD; Ma W; Colizzo FP; Carolan PJ; Nishioka NS; Staller K; Richter JM; Khalili H; Gala MK; Garber JJ; Chung DC; Yarze JC; Zukerberg L; Petrucci G; Rocca B; Patrono C; Milne GL; Wang M; Chan AT
    Cancer Prev Res (Phila); 2020 Oct; 13(10):877-888. PubMed ID: 32718943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Difluoromethylornithine and Aspirin for Treatment of Adenomas and Aberrant Crypt Foci in Patients with Prior Advanced Colorectal Neoplasms.
    Sinicrope FA; Velamala PR; Song LMWK; Viggiano TR; Bruining DH; Rajan E; Gostout CJ; Kraichely RE; Buttar NS; Schroeder KW; Kisiel JB; Larson MV; Sweetser SR; Sedlack RR; Sinicrope SN; Richmond E; Umar A; Della'Zanna G; Noaeill JS; Meyers JP; Foster NR
    Cancer Prev Res (Phila); 2019 Nov; 12(11):821-830. PubMed ID: 31484660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma lipoxin A
    Fedirko V; McKeown-Eyssen G; Serhan CN; Barry EL; Sandler RS; Figueiredo JC; Ahnen DJ; Bresalier RS; Robertson DJ; Anderson CW; Baron JA
    Mol Carcinog; 2017 Aug; 56(8):1977-1983. PubMed ID: 28218420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial.
    Drew DA; Chin SM; Gilpin KK; Parziale M; Pond E; Schuck MM; Stewart K; Flagg M; Rawlings CA; Backman V; Carolan PJ; Chung DC; Colizzo FP; Freedman M; Gala M; Garber JJ; Huttenhower C; Kedrin D; Khalili H; Kwon DS; Markowitz SD; Milne GL; Nishioka NS; Richter JM; Roy HK; Staller K; Wang M; Chan AT
    Trials; 2017 Feb; 18(1):50. PubMed ID: 28143522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin and folic acid for the prevention of recurrent colorectal adenomas.
    Logan RF; Grainge MJ; Shepherd VC; Armitage NC; Muir KR;
    Gastroenterology; 2008 Jan; 134(1):29-38. PubMed ID: 18022173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variants downstream of the ornithine decarboxylase gene influence risk of colorectal adenoma and aspirin chemoprevention.
    Barry EL; Mott LA; Sandler RS; Ahnen DJ; Baron JA
    Cancer Prev Res (Phila); 2011 Dec; 4(12):2072-82. PubMed ID: 21930798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
    Sandler RS; Halabi S; Baron JA; Budinger S; Paskett E; Keresztes R; Petrelli N; Pipas JM; Karp DD; Loprinzi CL; Steinbach G; Schilsky R
    N Engl J Med; 2003 Mar; 348(10):883-90. PubMed ID: 12621132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas.
    Huls G; Koornstra JJ; Kleibeuker JH
    Lancet; 2003 Jul; 362(9379):230-2. PubMed ID: 12885487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
    Sandler RS
    Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of aspirin and metformin combination therapy in patients with rectal aberrant crypt foci: a double-blinded randomized controlled trial.
    Higurashi T; Arimoto J; Ashikari K; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Nakajima A
    BMC Cancer; 2020 Oct; 20(1):1043. PubMed ID: 33121471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body Composition and Aspirin Dose for Colorectal Adenoma Prevention in a Randomized Clinical Trial.
    Passarelli MN; Barry EL; Rees JR; Mott LA; Ahnen DJ; Baron JA
    Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1262-1265. PubMed ID: 31263057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin helps prevent recurring colorectal adenomas--folic acid does not.
    Lundberg GD
    Medscape J Med; 2008 Mar; 10(3):69. PubMed ID: 18449348
    [No Abstract]   [Full Text] [Related]  

  • 17. Aspirin, Calcitriol, and Calcium Do Not Prevent Adenoma Recurrence in a Randomized Controlled Trial.
    Pommergaard HC; Burcharth J; Rosenberg J; Raskov H
    Gastroenterology; 2016 Jan; 150(1):114-122.e4. PubMed ID: 26404953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
    Gill S; Sinicrope FA
    Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of vitamin D and calcium on expression of MSH2 and transforming growth factors in normal-appearing colorectal mucosa of sporadic colorectal adenoma patients: A randomized clinical trial.
    Kwan AK; Um CY; Rutherford RE; Seabrook ME; Barry EL; Fedirko V; Baron JA; Bostick RM
    Mol Carcinog; 2019 Apr; 58(4):511-523. PubMed ID: 30499618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin in the chemoprevention of colorectal neoplasia: an overview.
    Chan AT; Arber N; Burn J; Chia WK; Elwood P; Hull MA; Logan RF; Rothwell PM; Schrör K; Baron JA
    Cancer Prev Res (Phila); 2012 Feb; 5(2):164-78. PubMed ID: 22084361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.